The public BPO companies — Teleperformance, Concentrix, and TTEC Holdings — are squarely in the crosshairs because their cost bases are overwhelmingly human. If AI can perform a rising share of voice and chat interactions autonomously, their core profit engine stalls. The fundamental picture at TTEC illustrates the pressure already mounting: Q1 2026 revenue dropped to $496.2 million from $534.2 million a year earlier, and the company swung to a net loss of $7.6 million, with operating income falling to just 3.7% of revenue .
Short sellers are disclosing significant bets against these names, and the data reveals that the trade is broad, concentrated, and led by some of the world's most influential hedge funds.
Teleperformance has become the single most-shorted company in France by the number of identified fund managers. As of April 2026, twelve separate funds hold disclosed short positions against the company . The heavyweight short sellers active in French equities — Marshall Wace, AQR Capital, Citadel, DE Shaw, QUBE, and Two Sigma — are all involved
.
As of late May 2026, a total of 535 individual historical short positions have been processed and recorded for Teleperformance, with the most recently disclosed short representing 2.25% of capital . In April 2026, an AMF filing revealed that Citadel Advisors had opened a 1.41% net short position in the stock
.
On the NASDAQ, TTEC's short interest is extraordinarily high. As of the April 30, 2026 settlement date, 6.51 million shares of TTEC were sold short, representing roughly 31.9% of the company's public float . The days-to-cover ratio stood at 9.88 trading days, indicating a highly crowded trade that could be prone to a sharp, violent squeeze if sentiment were to reverse
.
Institutional sentiment is reflecting this growing bearishness. In the most recent reporting quarter, 61 institutional investors decreased their positions in TTEC, while only 47 added shares . Five Wall Street analysts currently rate the stock a consensus "Reduce" with a 12-month price target of just $3.50
.
While specific short-interest percentages for Concentrix (NASDAQ: CNXC) were not publicly available in the data, the company is consistently grouped alongside Teleperformance and TTEC in industry analyses as facing the same structural AI disruption risk . MarketScreener's analysis frames the competition for both Teleperformance and Concentrix as "existential" — both must rapidly prove they can generate more revenue from AI-augmented services than they lose from the automation of their traditional labour-intensive work
.
The BPO short is not a standalone stock-picker's bet; it is a logical extension of the most powerful hedge fund trade of 2026. According to Goldman Sachs data, hedge funds have made a historic "all in" pivot to AI-linked equities . The CFS Rating Hedge Fund Trend Monitor shows that funds entered Q2 2026 with the highest long weight in semiconductors on record (10% of portfolios). In stark contrast, the allocation to software has dropped to 6%, the lowest level since 2019
.
This dual movement — long AI infrastructure, short at-risk incumbents — has created a fertile environment for long/short equity strategies . The selloff has spread in a cascading pattern across the economy. It began in software in late January 2026 after Anthropic's AI legal tool triggered a $285 billion market rout, which netted short-sellers $24 billion in gains as software ETFs fell over 8% in a single week
. From there, the panic rotated through insurance, trucking and logistics, and commercial real estate in a "shoot first, ask questions later" mode
. Short-sellers specifically targeted "vulnerable automation providers" — a category into which call centre and BPO operators naturally fall
.
The targeted companies are not passively accepting the narrative that they will be "Ubered" by AI. Their counterargument centers on transforming themselves from pure labour providers into AI-powered platform businesses that augment humans rather than replace them outright.
Concentrix is differentiating through its proprietary iX product suite. Its centerpiece is iX Hero, an agentic AI application launched in May 2025. The system acts as a real-time co-pilot for human advisors, listening to live calls, surfacing relevant knowledge articles, and suggesting the best next action. The company says this AI-augmented approach has reduced handling times by 25-30% while keeping a human firmly in the loop for complex problem-solving and compliance oversight .
Teleperformance is leveraging its massive scale — over 9 million daily interactions across 300+ languages — as a competitive moat. It has launched more than 500 AI projects and is embedding generative AI into virtual agents, agent-assist tools, quality assurance, and real-time translation . The strategic pitch is that large enterprises, which must deploy AI across dozens of languages and regulatory regimes (GDPR, HIPAA, PCI-DSS), will need a partner with existing infrastructure and client relationships. In this view, a full rip-and-replace with pure-AI vendors is too risky in the near term, and a hybrid human-AI model benefits incumbents who already own both the labour force and the client trust.
The critical caveat comes from the companies themselves. In its own 10-K filing, Concentrix explicitly warns investors that the rapid adoption of generative and agentic AI could "disrupt its labor-intensive model by automating customer interactions faster than anticipated" . Teleperformance's recent CEO transition further signals that the company recognizes an urgent need for new leadership to steer its pivot toward AI services
. The industry is racing to adapt, but that race is precisely against the market's judgment that AI will erode their revenue base faster than they can reinvent it.
Comments
0 comments